First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

NCT07177508 · clinicaltrials.gov ↗

COMPLETED

Status

2355

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Syncytial Viral (RSV) Infection
Respiratory Syncytial Virus Hospitalizations
Respiratory Syncytial Virus Prevention

Sponsor

Nicola Irwin